These medications mimic a hormone in the body that helps control appetite, fullness, and digestion
I was calling all over the state
family history, physical inactivity, high-risk ethnicity, poor diet, hypertension, dyslipidemia, PCOS, prior gestational diabetes, prediabetes, or cardiovascular disease All adults aged 45 or older, regardless of weight Children aged 10 or older with overweight or obesity and two or more risk factors, screened at puberty onset Pregnant individuals: gestational diabetes screening at 2428 weeks New in ADA 2026 Screen individuals initiating immune checkpoint inhibitors, PI3K inhibitors, mTOR inhibitors, or high-dose glucocorticoids, a significant new addition for oncology and transplant patients
Once the prescribed dose is showing, its injected under the skin
Eligibility for these medications depends on specific health criteria, with a primary focus on body mass index (BMI)
Semaglutide and Tirzepatide are both FDA-approved and have undergone extensive clinical trials